Joseph Tripodi
Overview
Explore the profile of Joseph Tripodi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
553
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Marcellino B, Hoffman R, Tripodi J, Lu M, Kosiorek H, Mascarenhas J, et al.
Blood Adv
. 2018 Dec;
2(24):3581-3589.
PMID: 30563882
The Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocythemia (ET), and the prefibrotic form of primary myelofibrosis (PMF), frequently progress to more overt forms of MF and...
12.
Zimran E, Tripodi J, Rampal R, Rappoport F, Zirkiev S, Hoffman R, et al.
Haematologica
. 2018 May;
103(10):e446-e449.
PMID: 29748436
No abstract available.
13.
Hernandez-Prera J, Kwan R, Tripodi J, Chiosea S, Cordon-Cardo C, Najfeld V, et al.
Head Neck
. 2016 Nov;
39(3):503-511.
PMID: 27898192
Background: Hyalinizing clear cell carcinoma (HCCC) is a rare malignancy, characterized by EWSR1-ATF1 gene fusion, whose behavior is poorly understood, as it was for many years considered a diagnosis of...
14.
Hanna M, Najfeld V, Irie H, Tripodi J, Nayak A
Springerplus
. 2015 Aug;
4:439.
PMID: 26312204
ALK has emerged as a novel tumorigenic factor in several epithelial human cancers. Crizotinib, an ALK tyrosine kinase inhibitor, is currently approved to treat lung cancer patients exhibiting ALK gene...
15.
Zou H, Feng R, Huang Y, Tripodi J, Najfeld V, Tsankova N, et al.
Sci Rep
. 2015 Feb;
5:8468.
PMID: 25683249
In primary brain tumors, oncogenes are frequently amplified and maintained on extrachromosomal DNA as double minutes (DM), but the underlying mechanisms remain poorly understood. We have generated a mouse model...
16.
Wang X, Ye F, Tripodi J, Hu C, Qiu J, Najfeld V, et al.
Blood
. 2014 Sep;
124(19):2987-95.
PMID: 25193869
Dysregulation of Janus kinase (JAK)-signal transducer and activator of transcription signaling is central to the pathogenesis of myelofibrosis (MF). JAK2 inhibitor therapy in MF patients results in a rapid reduction...
17.
Wang X, Tripodi J, Kremyanskaya M, Blouin A, Roda P, Hoffman R, et al.
Blood
. 2013 Feb;
121(7):1238-9.
PMID: 23411734
No abstract available.
18.
Wang X, Prakash S, Lu M, Tripodi J, Ye F, Najfeld V, et al.
J Clin Invest
. 2012 Oct;
122(11):3888-99.
PMID: 23023702
Cancer stem cell behavior is thought to be largely determined by intrinsic properties and by regulatory signals provided by the microenvironment. Myelofibrosis (MF) is characterized by hematopoiesis occurring not only...
19.
Lu M, Wang X, Li Y, Tripodi J, Mosoyan G, Mascarenhas J, et al.
Blood
. 2012 Aug;
120(15):3098-105.
PMID: 22872685
Interferon (IFN-α) is effective therapy for polycythemia vera (PV) patients, but it is frequently interrupted because of adverse events. To permit the long-term use of IFN, we propose combining low...
20.
Rickman D, Soong T, Moss B, Mosquera J, Dlabal J, Terry S, et al.
Proc Natl Acad Sci U S A
. 2012 May;
109(23):9083-8.
PMID: 22615383
Emerging evidence suggests that chromatin adopts a nonrandom 3D topology and that the organization of genes into structural hubs and domains affects their transcriptional status. How chromatin conformation changes in...